Add Company
Join Now

SeraNovo Revenue and Competitors

License our Company Data API

Leiden,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • SeraNovo's estimated annual revenue is currently $3.2M per year.(i)
  • SeraNovo's estimated revenue per employee is $201,000

Employee Data

  • SeraNovo has 16 Employees.(i)
  • SeraNovo grew their employee count by 23% last year.

SeraNovo's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Chief Development OfficerReveal Email/Phone
4
Senior Formulation ScientistReveal Email/Phone
5
Formulation ScientistReveal Email/Phone
6
Formulation ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is SeraNovo?

SeraNovo is a privately held Dutch pharmaceutical company with a proprietary technology platform to enhance the bioavailability of water insoluble drugs. SeraNovo's technology harnesses the unique benefits of deep eutectic solvents to create powerful, tailor-made solubility-enhancing formulations that are well tolerated and simple to produce. Since its incorporation in 2017, the company has secured multiple license deals, validating the potential of its technology. SeraNovo has a broad portfolio of programs progressing through clinical phases in 2021 and an established suit of intellectual property.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$3.2M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M167%N/A
#2
$3.3M215%N/A
#3
$2.2M22-21%N/A
#4
N/A25108%N/A
#5
$4.3M288%N/A